ImmuCell Corporation (ICCC)

NASDAQ: ICCC · Delayed Price · USD
8.15
-0.35 (-4.12%)
At close: May 25, 2022 4:00 PM
8.30
0.15 (1.84%)
After-hours:May 25, 2022 4:00 PM EDT
Market Cap63.10M
Revenue (ttm)21.14M
Net Income (ttm)1.10M
Shares Out7.74M
EPS (ttm)0.14
PE Ratio59.49
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,066
Open8.58
Previous Close8.50
Day's Range8.13 - 8.59
52-Week Range7.30 - 10.96
Beta0.67
AnalystsBuy
Price Targetn/a
Earnings DateMay 12, 2022

About ICCC

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, ...

IndustryBiotechnology
IPO DateApr 30, 1987
CEOMichael Brigham
Employees60
Stock ExchangeNASDAQ
Ticker SymbolICCC
Full Company Profile

Financial Performance

In 2021, ImmuCell's revenue was $19.24 million, an increase of 25.43% compared to the previous year's $15.34 million. Losses were -$78,292, -92.34% less than in 2020.

Financial Statements

News

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

PORTLAND, Maine, May 19, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientificall...

6 days ago - GlobeNewsWire

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022

Q1 2022 Product Sales Increased 46% over Q1 2021 Q1 2022 Product Sales Increased 46% over Q1 2021

1 week ago - GlobeNewsWire

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022

Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ET Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ET

2 weeks ago - GlobeNewsWire

UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- Certain immaterial corrections have been made to the second and fifth paragraphs.

2 weeks ago - GlobeNewsWire

Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientificall...

2 weeks ago - GlobeNewsWire

ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022

PORTLAND, Maine, April 11, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifica...

1 month ago - GlobeNewsWire

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021

Annual Product Sales for 2021 Increased 25% over 2020 Annual Product Sales for 2021 Increased 25% over 2020

3 months ago - GlobeNewsWire

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021

Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET

3 months ago - GlobeNewsWire

ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021

PORTLAND, Maine, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifical...

4 months ago - GlobeNewsWire

ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021

Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000) Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000)

6 months ago - GlobeNewsWire

ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021

Conference Call Scheduled for Tuesday, November 16, 2021 at 9:00 AM ET Conference Call Scheduled for Tuesday, November 16, 2021 at 9:00 AM ET

6 months ago - GlobeNewsWire

ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021

PORTLAND, Maine, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifical...

7 months ago - GlobeNewsWire

Raffael Lichdi, DVM Joins ImmuCell's Sales & Marketing Team

PORTLAND, Maine, Sept. 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifica...

8 months ago - GlobeNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC

New York, New York--(Newsfile Corp. - September 2, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation ("ImmuCell" or the "Company") (NASDAQ: ICCC). Such investo...

8 months ago - Newsfile Corp

ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®

PORTLAND, Maine, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifical...

9 months ago - GlobeNewsWire

ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021

Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000) Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000)

9 months ago - GlobeNewsWire

ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021

Conference Call Scheduled for Friday, August 13, 2021 at 9:00 AM ET Conference Call Scheduled for Friday, August 13, 2021 at 9:00 AM ET

9 months ago - GlobeNewsWire

ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021

PORTLAND, Maine, July 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifical...

10 months ago - GlobeNewsWire

ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021

PORTLAND, Maine, May 13, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientificall...

1 year ago - GlobeNewsWire

ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021

Conference Call Scheduled for Friday, May 14, 2021 at 9:00 AM ET Conference Call Scheduled for Friday, May 14, 2021 at 9:00 AM ET

1 year ago - GlobeNewsWire

ImmuCell Closes $4,250,000 Equity Financing

PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifica...

1 year ago - GlobeNewsWire

ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021

PORTLAND, Maine, April 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifica...

1 year ago - GlobeNewsWire

ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December ...

PORTLAND, Maine , Feb. 22, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifica...

1 year ago - GlobeNewsWire

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020

Conference Call Scheduled for Tuesday, February 23, 2021 at 9:00 AM ET Conference Call Scheduled for Tuesday, February 23, 2021 at 9:00 AM ET

1 year ago - GlobeNewsWire

ImmuCell Announces Restructuring of its Bank Debt

PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifical...

1 year ago - GlobeNewsWire